These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32845785)

  • 1. Key Players of Hepatic Fibrosis.
    Dawood RM; El-Meguid MA; Salum GM; El Awady MK
    J Interferon Cytokine Res; 2020 Oct; 40(10):472-489. PubMed ID: 32845785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
    Wasmuth HE; Lammert F; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.
    Elpek GÖ
    World J Gastroenterol; 2014 Jun; 20(23):7260-76. PubMed ID: 24966597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of hepatic stellate cells with diverse types of immune cells: foe or friend?
    Yi HS; Jeong WI
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():99-104. PubMed ID: 23855303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic stellate cells and the reversal of fibrosis.
    Kisseleva T; Brenner DA
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatic fibrogenesis].
    Lee KS
    Korean J Gastroenterol; 2006 Nov; 48(5):297-305. PubMed ID: 17132917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
    Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic stellate cells: a target for the treatment of liver fibrosis.
    Wu J; Zern MA
    J Gastroenterol; 2000; 35(9):665-72. PubMed ID: 11023037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. siRNA- and miRNA-based therapeutics for liver fibrosis.
    Zhao Z; Lin CY; Cheng K
    Transl Res; 2019 Dec; 214():17-29. PubMed ID: 31476281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis.
    He L; Yuan H; Liang J; Hong J; Qu C
    PLoS One; 2020; 15(5):e0233702. PubMed ID: 32442221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.
    Mormone E; George J; Nieto N
    Chem Biol Interact; 2011 Sep; 193(3):225-31. PubMed ID: 21803030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of hepatic fibrosis.
    Hui AY; Friedman SL
    Expert Rev Mol Med; 2003 Feb; 5(5):1-23. PubMed ID: 14987408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
    Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
    Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.
    Sepulveda-Crespo D; Resino S; Martinez I
    Drugs; 2021 Mar; 81(4):419-443. PubMed ID: 33400242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.
    Su TH; Kao JH; Liu CJ
    Int J Mol Sci; 2014 Jun; 15(6):10578-604. PubMed ID: 24927147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2X7R orchestrates the progression of murine hepatic fibrosis by making a feedback loop from macrophage to hepatic stellate cells.
    Jiang M; Cui BW; Wu YL; Zhang Y; Shang Y; Liu J; Yang HX; Qiao CY; Zhan ZY; Ye H; Jin Q; Nan JX; Lian LH
    Toxicol Lett; 2020 Oct; 333():22-32. PubMed ID: 32721574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
    Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
    Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
    Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
    Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advancement of molecular mechanisms of liver fibrosis.
    Seki E; Brenner DA
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):512-8. PubMed ID: 25869468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.